Silver Book Fact

Life expectancy and quality of life gains from AVR

A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years gained at a net value of $11.2 billion (~$14.2 billion in 2017 dollars).

Wu Y, Grunkmeier G, Starr A. The Value of Aortic Valve Replacement in Elderly Patients: An economic analysis. Journal of Thoracic and Cardiovascular Surgery. 2007; 133(3): 603-7. http://www.jtcvsonline.org/article/S0022-5223(06)01477-2/fulltext

Reference

Title
The Value of Aortic Valve Replacement in Elderly Patients: An economic analysis
Publication
Journal of Thoracic and Cardiovascular Surgery
Publication Date
2007
Authors
Wu Y, Grunkmeier G, Starr A
Volume & Issue
Volume 133, Issue 3
Pages
603-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Undertreatment of patients with sSAS
    AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.  
  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…  
  • TAVR Procedures 2011 – 2015
    From approval in 2011 through 2015, >54,000 transcatheter aortic valve replacements (TAVRs) were performed in 418 centers in 48 states.  
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…